Clinical Observation of Adverse Events of Immune Checkpoint Inhibitors in 20 Advanced Tumor Patients and Literature Reviews

Clinical Observation of Adverse Events of Immune Checkpoint Inhibitors in 20 Advanced Tumor Patients and Literature Reviews

Objective To observe the toxicities of immune checkpoint inhibitors. Methods We retrospectively analyzed the clinical data of 20 advanced tumor patients who received immune checkpoint inhibitors therapy in Cancer Hospital of Chinese Academy of Medical Sciences from March 2017 to August 2019, and col...

Full description

Bibliographic Details
Main Authors:	WANG Xue, YUAN Peng, YUE Jian, SI Yiran, HU Nanlin, ZHENG Fangchao, JIANG Peidi
Format:	Article
Language:	zho
Published:	Magazine House of Cancer Research on Prevention and Treatment 2020-06-01
Series:	Zhongliu Fangzhi Yanjiu
Subjects:	immune checkpoint inhibitors immune-related adverse events immunotherapy
Online Access:	http://html.rhhz.net/ZLFZYJ/html/8578.2020.19.1554.htm

Similar Items

Management of immune checkpoint inhibitor‐related adverse events: A review of case reports
by: Xiaoyan Si, et al.
Published: (2020-03-01)

Perspectives on Psoriasiform Adverse Events from Immune Checkpoint Inhibitors: Lessons Learned from Our Practice
by: Liliana Gabriela Popa, et al.
Published: (2024-02-01)

Characterization and Prognostic Significance of Cutaneous Immune-Related Adverse Events in Indian Patients on Immune Checkpoint Inhibitor Therapy
by: Prasanna Duraisamy, et al.
Published: (2023-07-01)

Establishment of an animal model of immune‐related adverse events induced by immune checkpoint inhibitors
by: Yuan Meng, et al.
Published: (2024-07-01)

The assessment of rheumatologic immune-related adverse events with immune checkpoint inhibitors
by: Emre Tekgöz, et al.
Published: (2022-03-01)

Exploration of Germline Correlates and Risk of Immune-Related Adverse Events in Advanced Cancer Patients Treated with Immune Checkpoint Inhibitors
by: Emma Titmuss, et al.
Published: (2024-03-01)

Immune checkpoint inhibitor-related adverse cardiac events in patients with lung cancer: a systematic review and meta-analysis
by: Xiao-Tong Zhang, et al.
Published: (2022-11-01)

Recommendations and exploration of diagnosis and treatment of critical and refractory immune checkpoint inhibitor‐associated adverse events
by: Peng Song, et al.
Published: (2020-08-01)

Clinical Diagnosis and Treatment of Immune-related Adverse Events in Digestive System Related to Immune Checkpoint Inhibitors
by: Yue LI, et al.
Published: (2019-10-01)

Managing Select Immune-Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitors
by: Parneet K. Cheema, et al.
Published: (2024-10-01)

Psychiatric disorders associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) databaseResearch in context
by: Chaozheng Zhou, et al.
Published: (2023-05-01)

Cardiovascular adverse events induced by immune checkpoint inhibitors: A real world study from 2018 to 2022
by: Si Wu, et al.
Published: (2022-08-01)

Rheumatological Adverse Events Following Immunotherapy for Cancer
by: Ioana Cretu, et al.
Published: (2022-01-01)

Ocular adverse events associated with immune checkpoint inhibitors, a scoping review
by: A. Martens, et al.
Published: (2023-02-01)

Pancreatic adverse events in patients treated with immune checkpoint inhibitors
by: Caroline Hana, et al.
Published: (2023-03-01)

Updated Brazilian guidelines for the management of immune-related adverse events associated with checkpoint inhibitors - edition 2.0
by: Rodrigo Ramella Munhoz, et al.
Published: (2022-10-01)

Rheumatic Immune-Related Adverse Events—A Consequence of Immune Checkpoint Inhibitor Therapy
by: Anca Bobircă, et al.
Published: (2021-06-01)

Management of immune checkpoint inhibitor‐related dermatologic adverse events
by: Xiaoyan Si, et al.
Published: (2020-02-01)

Advances in Predictive Research of Immune Checkpoint Inhibitors-related  Adverse Events
by: Jing ZHANG, et al.
Published: (2023-10-01)

Immune-related adverse events of immune checkpoint inhibitors: a review
by: Qinan Yin, et al.
Published: (2023-05-01)

Ophthalmic immune-related adverse events associated with immune checkpoint inhibitors
by: Linyang Gan, et al.
Published: (2023-03-01)

The Impact of Immune Checkpoint Inhibitor-Related Adverse Events and Their Immunosuppressive Treatment on Patients’ Outcomes
by: Hamzah Abu-Sbeih, et al.
Published: (2018-07-01)

Pancreatic adverse events of immune checkpoint inhibitors therapy for solid cancer patients: a systematic review and meta-analysis
by: Zhe Zhao, et al.
Published: (2023-06-01)

Risk factors for cardiovascular adverse events from immune checkpoint inhibitors
by: Lingli Luo, et al.
Published: (2023-04-01)

Hepatotoxicity induced by immune checkpoint inhibitors
by: Flaviu Muresan, et al.
Published: (2024-10-01)

A case of polyserositis, chylous ascites and hepatitis induced by immune checkpoint-inhibitors
by: Marta Castelli, et al.
Published: (2024-05-01)

Immune-Mediated Adverse Effects of Checkpoint Inhibitors: A Clinical Experience
by: Juřica Jan, et al.
Published: (2022-06-01)

A new frontier in treatment of advanced melanoma: Redefining clinical management in the era of immune checkpoint inhibitors
by: Oren Levine, et al.
Published: (2017-08-01)

Characterising immune-related adverse events in different types of cancer among Chinese patients receiving immune checkpoint inhibitors
by: Qi Zhang, et al.
Published: (2024-12-01)

Are immune-related adverse events associated with the efficacy of immune checkpoint inhibitors in patients with cancer? A systematic review and meta-analysis
by: Xiaoxiang Zhou, et al.
Published: (2020-04-01)

Toxicity Associated with Immune Checkpoint Inhibitors: Analysis of Immune-Related Adverse Events with a Pembrolizumab Biosimilar (Pembroria)
by: M. Yu. Fedyanin, et al.
Published: (2023-06-01)

Immune checkpoint inhibitor‐mediated psoriasis treated with biologics
by: Pei Ming Yeo, et al.
Published: (2023-06-01)

Leveraging high-resolution omics data for predicting responses and adverse events to immune checkpoint inhibitors
by: Angelo Limeta, et al.
Published: (2023-01-01)

Meta‐analysis of immune‐related adverse events of immune checkpoint inhibitor therapy in cancer patients
by: Peng Song, et al.
Published: (2020-09-01)

A Potential Pneumothorax Induced by Immune Checkpoint Inhibitors: A Case Report and Literature Review
by: Yoon-E Shin, et al.
Published: (2024-10-01)

Comparison of immune checkpoint inhibitors related to pulmonary adverse events: a retrospective analysis of clinical studies and network meta-analysis
by: Baohui Hong, et al.
Published: (2024-02-01)

Rheumatic immune-related adverse events from checkpoint inhibitor therapy: a case series
by: Antonella Laria, et al.
Published: (2021-08-01)

Cardiovascular events after the initiation of immune checkpoint inhibitors
by: Yuta Suzuki, et al.
Published: (2023-05-01)

The use of biologic medications for the treatment of cutaneous immune-related adverse events secondary to immune checkpoint inhibitors: A single-institution real-life study
by: Jade N. Young, BS, et al.
Published: (2024-01-01)

Immune checkpoint Inhibitor related myocarditis reported through the FDA adverse event reporting system: pharmacovigilance trends in reporting and outcomes
by: David J. Reeves, et al.
Published: (2025-02-01)